Evidence map›Paper›PMID 25961570›Full record

ArticlePloS one2015

Chaperone-Mediated Autophagy Targets IFNAR1 for Lysosomal Degradation in Free Fatty Acid Treated HCV Cell Culture.

Ramazan Kurt, Partha K Chandra, Fatma Aboulnasr, Rajesh Panigrahi, Pauline Ferraris, Yucel Aydin, Krzysztof Reiss, Tong Wu, Luis A Balart, Srikanta Dash

Expression of concernOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It carries an expression of concern. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Autophagy in liver diseases.World journal of hepatology · 2021
    Review
  7. The Role of Chaperone-Mediated Autophagy in Hepatitis C Virus-Induced Pathogenesis.Frontiers in cellular and infection microbiology · 2021
    Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Diverse Functions of Autophagy in Liver Physiology and Liver Diseases.International journal of molecular sciences · 2019
    Review
  15. The Multifaceted Roles of Autophagy in Flavivirus-Host Interactions.International journal of molecular sciences · 2018
    Review
  16. Article
  17. Article
  18. Review
  19. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Ramazan KurtDepartment of Medicine, Division of Gastroenterology and Hepatology, Tulane University School of Medicine, New Orleans, Louisiana, United States of America.
Partha K ChandraPathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, Louisiana, United States of America.
Fatma AboulnasrPathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, Louisiana, United States of America.
Rajesh PanigrahiPathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, Louisiana, United States of America.
Pauline FerrarisPathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, Louisiana, United States of America.
Yucel AydinDepartment of Medicine, Division of Gastroenterology and Hepatology, Tulane University School of Medicine, New Orleans, Louisiana, United States of America.
Krzysztof ReissNeurological Cancer Research, Stanley S Scott Cancer Center, LSU Health Science Center, New Orleans, Louisiana, United States of America.
Tong WuDepartment of Medicine, Division of Gastroenterology and Hepatology, Tulane University School of Medicine, New Orleans, Louisiana, United States of America.
Luis A BalartDepartment of Medicine, Division of Gastroenterology and Hepatology, Tulane University School of Medicine, New Orleans, Louisiana, United States of America.
Srikanta DashDepartment of Medicine, Division of Gastroenterology and Hepatology, Tulane University School of Medicine, New Orleans, Louisiana, United States of America; Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, Louisiana, United States of America.
Tulane University · USLouisiana State University Health Sciences Center New Orleans · US

Funding

Hepatitis C Virus and Hepatocellular CarcinomaR01CA089121 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI DASH, SRIKANTA · 2001 to 2016
$2.7M
IL-28B genotype and HCV treatment clearanceR01AI103106 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI DASH, SRIKANTA · 2013 to 2016
$1.5M
Hepatocarcinogenesis Secondary to Hepatitis CR01CA127481 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI DASH, SRIKANTA · 2008 to 2012
$1.4M
NCI NIH HHS CA089121NCI NIH HHS CA127481NCI NIH HHS R01 CA089121NCI NIH HHS R01 CA127481NIAID NIH HHS AI103106NIAID NIH HHS R01 AI103106
6 · The paper itself

Abstract

backgroundHepatic steatosis is a risk factor for both liver disease progression and an impaired response to interferon alpha (IFN-α)-based combination therapy in chronic hepatitis C virus (HCV) infection. Previously, we reported that free fatty acid (FFA)-treated HCV cell culture induces hepatocellular steatosis and impairs the expression of interferon alpha receptor-1 (IFNAR1), which is why the antiviral activity of IFN-α against HCV is impaired.

aimTo investigate the molecular mechanism by which IFNAR1 expression is impaired in HCV cell culture with or without free fatty acid-treatment.

methodHCV-infected Huh 7.5 cells were cultured with or without a mixture of saturated (palmitate) and unsaturated (oleate) long-chain free fatty acids (FFA). Intracytoplasmic fat accumulation in HCV-infected culture was visualized by oil red staining. Clearance of HCV in FFA cell culture treated with type I IFN (IFN-α) and Type III IFN (IFN-λ) was determined by Renilla luciferase activity, and the expression of HCV core was determined by immunostaining. Activation of Jak-Stat signaling in the FFA-treated HCV culture by IFN-α alone and IFN-λ alone was examined by Western blot analysis and confocal microscopy. Lysosomal degradation of IFNAR1 by chaperone-mediated autophagy (CMA) in the FFA-treated HCV cell culture model was investigated.

resultsFFA treatment induced dose-dependent hepatocellular steatosis and lipid droplet accumulation in HCV-infected Huh-7.5 cells. FFA treatment of infected culture increased HCV replication in a concentration-dependent manner. Intracellular lipid accumulation led to reduced Stat phosphorylation and nuclear translocation, causing an impaired IFN-α antiviral response and HCV clearance. Type III IFN (IFN-λ), which binds to a separate receptor, induces Stat phosphorylation, and nuclear translocation as well as antiviral clearance in FFA-treated HCV cell culture. We show here that the HCV-induced autophagy response is increased in FFA-treated cell culture. Pharmacological inhibitors of lysosomal degradation, such as ammonium chloride and bafilomycin, prevented IFNAR1 degradation in FFA-treated HCV cell culture. Activators of chaperone-mediated autophagy, including 6-aminonicotinamide and nutrient starvation, decreased IFNAR1 levels in Huh-7.5 cells. Co-immunoprecipitation, colocalization and siRNA knockdown experiments revealed that IFNAR1 but not IFNLR1 interacts with HSC70 and LAMP2A, which are core components of chaperone-mediated autophagy (CMA).

conclusionOur study presents evidence indicating that chaperone-mediated autophagy targets IFNAR1 degradation in the lysosome in FFA-treated HCV cell culture. These results provide a mechanism for why HCV induced autophagy response selectively degrades type I but not the type III IFNAR1.

Indexed as

Antiviral AgentsAutophagyCell LineCells, CulturedFatty Acids, NonesterifiedFatty LiverGene ExpressionHepacivirusHumansInterferon-gammaInterferon Type IJanus KinasesLysosomesPhosphorylationProtein BindingProteolysisAntiviral AgentsFatty Acids, NonesterifiedIFNAR1 protein, humanInterferon-gammaInterferon Type IJanus KinasesReceptor, Interferon alpha-betaSTAT Transcription Factors

Identifiers

PMID25961570
PMCPMC4427131
OpenAlexW291313901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.